American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) . Washington, DC: APA.
Anderson, I. M. (1998) SSRIs versus tricyclic antidepressants in depressed in-patients: A meta-analysis of efficacy and tolerability. Depression and Anxiety, 7 (suppl. 1), 11–17.
Anderson, I. M. & Tomenson, B. M. (1994) The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. Journal of Psychopharmacology, 8, 238–249.
Anderson, I. M. & Tomenson, B. M. (1995) Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: A meta-analysis. British Medical Journal, 310, 1433–1438.
Ansseau, M. (1992) The Atlantic gap: clinical trials in Europe and the United States. Biological Psychiatry, 31, 109–111.
Bech, P. (1989) Clinical effects of selective serotonin reuptake inhibitors. In Clinical Pharmacology in Psychiatry (Psychopharmacology. Series 7) (eds Dahl, S. G. & Gram, L. F.), pp. 81–93. Berlin & Heidelberg: Springer-Verlag.
Bech, P. & Cialdella, P. (1992) Citalopram in depression: meta-analysis of intended and unintended effects. International Clinical Psychopharmacology, 6 (suppl. 5), 45–54.
Boissel, J. R., Blanchard, J., Panak, E., et al (1989) Considerations for the meta-analysis of randomized clinical trials. Summary of a panel discussion. Controlled Clinical Trials, 10, 254–281.
Cohen, J. (1977) Statistical Power Analysis for the Behavioral Sciences. Orlando, FL: Academic Press Inc.
Cucherat, M., Boissel, J. P., Leizorovicz, A., et al (1997) Easy MA: a program for the meta-analysis of clinical trials. Computer Methods and Programs in Biomedicine, 53, 187–190.
Frank, E., Prien, R. F., Jarrett, R. B., et al (1991) Conceptualisation and rationale for consensus definitions of terms in major depressive disorders. Archives of General Psychiatry, 48, 851–855.
Glass, G. V. (1976) Primary, secondary and meta-analysis of research. Review of Educational Research, 5, 3–9.
Greenberg, R. P., Bornstein, R. F., Zborowski, M. J., et al (1994) A meta-analysis of fluoxetine outcome in the treatment of depression. Journal of Nervous and Mental Disease, 182, 547–551.
Guy, W. (1976) ECDEU Assessments Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health.
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278–296.
Hedges, L. V. & Olkin, I. (1985) Statistical Methods for Meta-Analysis. New York: Academic Press.
Hotopf, M., Hardy, R. & Lewis, G. (1997) Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. British Journal of Psychiatry, 170, 120–127.
Laird, N. & DerSimonian, R. (1986) Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177–188.
Medical Research Council (1965) Clinical trial treatment of depressive illness. British Medical Journal, 1, 881–886.
O'Sullivan, R. L., Fava, M., Agustin, C., et al (1997) Sensitivity of the six-item Hamilton Depression Rating Scale. Acta Psychiatrica Scandinavica, 95, 379–384.
Review Manager (1997) Computer Programme Version 3.0.1. Oxford: Update Software
Smith, A., Traganza, E. & Harrison, G. (1969) Studies on the effectiveness of antidepressant drugs. Psychopharmacology Bulletin, suppl., 1–53.
Song, F., Freemantle, N., Sheldon, T. A., et al (1993) Selective serotonin reuptake inhibitors: a meta-analysis of efficacy and acceptability. British Medical Journal, 306, 683–687.
Spitzer, R. L., Endicott, J. & Robins, E. (1978) Research Diagnostic Criteria: Rationale and research reliability. Archives of General Psychiatry, 35, 773–785.
Whitehead, A. & Whitehead, J. (1991) A general parametric approach to the meta-analysis of randomized clinical trials. Statistics in Medicine, 10, 1665–1677.
World Health Organization (1978) Mental Disorders: Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases
. Geneva: WHO.